✦ LIBER ✦

Cooperative cell-growth inhibition by combination treatment with ZD1839 (Iressa) and trastuzumab (Herceptin) in non-small-cell lung cancer

✍ Scribed by Hisashi Nakamura; Shinzo Takamori; Teruhiko Fujii; Mayumi Ono; Hideaki Yamana; Michihiko Kuwano; Kazuo Shirouzu

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epidermal growth factor receptor targete

✍ Cappuzzo, Federico; Ardizzoni, Andrea; Soto-Parra, Hector; Gridelli, Cesare; Mai 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 270 KB

Combination treatment with Grb7 peptide

✍ Pero, S C; Shukla, G S; Cookson, M M; Flemer, S; Krag, D N 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 113 KB

Activity of ZD1839 (Gefitinib, Iressa™)

✍ Angelia D. Gibson; Mark Socinski; Chandra P. Belani; Vinay K. Jain 📂 Article 📅 2002 🏛 CIG Media Group, LP. 🌐 English ⚖ 79 KB

Effects of ZD1839 (Iressa, gefitinib) tr

✍ Ronald B Natale 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 240 KB

O-113 Clinical evaluation of gefitinib (

✍ O'Byrne, K.J.; Clarke, L.; Dunlop, D.; Ranson, Malcolm; Danson, S.; Botwood, N. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Dramatic effect of ZD1839 (‘Iressa’) in

✍ Fujiwara, Keiichi; Kiura, Katsuyuki; Ueoka, Hiroshi; Tabata, Masahiro; Hamasaki, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 111 KB